Generate Biomedicines, Inc. (GENB)
15.72
+0.33
(+2.14%)
USD |
NASDAQ |
Sep 11, 16:00
15.50
-0.22
(-1.40%)
After-Hours: 20:00
Generate Biomedicines Market Cap : 2.016B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.016B |
| September 10, 2026 | 1.974B |
| September 09, 2026 | 1.991B |
| September 08, 2026 | 2.039B |
| September 04, 2026 | 2.102B |
| September 03, 2026 | 2.096B |
| September 02, 2026 | 2.088B |
| September 01, 2026 | 2.025B |
| August 31, 2026 | 1.959B |
| August 28, 2026 | 1.966B |
| August 27, 2026 | 2.023B |
| August 26, 2026 | 2.070B |
| August 25, 2026 | 2.614B |
| August 24, 2026 | 2.273B |
| August 21, 2026 | 2.068B |
| August 20, 2026 | 2.051B |
| August 19, 2026 | 2.177B |
| August 18, 2026 | 2.063B |
| August 17, 2026 | 2.013B |
| August 14, 2026 | 2.006B |
| August 13, 2026 | 1.928B |
| August 12, 2026 | 1.936B |
| August 11, 2026 | 1.830B |
| August 10, 2026 | 1.888B |
| August 07, 2026 | 1.841B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.782B |
| August 05, 2026 | 1.859B |
| August 04, 2026 | 1.832B |
| August 03, 2026 | 1.838B |
| July 31, 2026 | 1.795B |
| July 30, 2026 | 1.799B |
| July 29, 2026 | 1.677B |
| July 28, 2026 | 1.684B |
| July 27, 2026 | 1.754B |
| July 24, 2026 | 1.718B |
| July 23, 2026 | 1.773B |
| July 22, 2026 | 1.782B |
| July 21, 2026 | 1.845B |
| July 20, 2026 | 1.741B |
| July 17, 2026 | 1.738B |
| July 16, 2026 | 1.751B |
| July 15, 2026 | 1.804B |
| July 14, 2026 | 1.822B |
| July 13, 2026 | 1.831B |
| July 10, 2026 | 1.836B |
| July 09, 2026 | 2.015B |
| July 08, 2026 | 2.034B |
| July 07, 2026 | 2.079B |
| July 06, 2026 | 2.169B |
| July 02, 2026 | 2.232B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 7.973B |
| Intellia Therapeutics, Inc. | 1.644B |
| Prime Medicine, Inc. | 565.71M |
| Moderna, Inc. | 57.44B |
| Beam Therapeutics, Inc. | 2.477B |
Market Cap Related Metrics
| PS Ratio | 39.01 |
| Price to Book Value | 4.422 |
| Price | 15.72 |
| Earnings Yield | -29.38% |